Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Sarah Grillo/Axios

The wide-ranging symptoms and many manifestations of COVID-19 are complicating efforts to treat the disease and stop its spread.

The big picture: There are very few diseases that everyone experiences the same. But the patterns of disease with COVID-19 are unusual compared to other recent pandemics, and it could usher in a new framework for thinking about disease.

The range of experiences in people infected with SARS-CoV-2, the virus that causes COVID-19, spans from no symptoms to hospitalization to death, an observation NIAID director Anthony Fauci and other experts have repeatedly made recently.

  • "In SARS-Cov-2 , there is an extreme divergence in host responses. We don’t yet know what is leading to that," says immunologist José Ordovas-Montañes of Boston Children's Hospital.

Details: Many people have mild symptoms of the disease — or none at all, meaning they can be unknowingly carrying and spreading the virus and complicating efforts to control its spread.

  • 40%–45% of people infected with SARS-CoV-2 don't develop symptoms, according to one estimate based on several case studies.
  • By comparison, 13% of health care workers infected with SARS-CoV-1, the virus behind the 2003 epidemic, were asymptomatic in one study in Singapore.
  • But for many respiratory viruses, the rate of infection without symptoms is more than 70%.

On the other end of the spectrum are those were are hospitalized, including roughly 1 in 5 older people who test positive for the disease.

  • Beyond pneumonia and acute respiratory distress syndrome, the long and varied list of common manifestations of COVID-19 in hospitalized patients includes cardiac, neurological, renal, hepatic, gastrointestinal, endocrine, thrombotic, and dermatological complications, according to a recent review by Aakriti Gupta of the Columbia University Irving Medical Center.
  • "This virus is proving to be more than just a respiratory virus in terms of the manifestations, which we've seen with other respiratory viruses," says Amesh Adalja, a senior scholar at the John Hopkins Center for Health Security.
  • Other viruses, like influenza, SARS-CoV-1 and Ebola, can affect the body in multiple ways.
  • But with COVID-19, "the proportion of people in which this multiple organ injury is occurring is higher than anything we’ve seen before," says Gupta. For example, 40%–50% of hospitalized COVID-19 patients and up to 80% of patients admitted to the ICU have acute kidney injury, usually in addition to lung injury, compared to about 7% of patients with SARS.

The intrigue: It's possible other pandemic viruses — like the 1918 flu — had a wide range of different outcomes, but the molecular tools and diagnostics didn't exist to spot them. Or in the case of the coronaviruses that cause the common cold and don't kill people, we don't pay attention to those differences or bother to look for them.

  • But COVID-19 does kill and, as data and science rapidly amass about the virus, the differences are more explicit — and more concerning.
  • "Each virus has this particular balance of the types of cases you are going to get," says Ordovas-Montañes. "This virus has particularly captivated our attention because of how balanced it is across that spectrum."

What's happening: Researchers are trying to tease out the factors behind COVID-19's range.

There is the virus itself. "Coronaviruses are unusual in that they attack both the respiratory and gastrointestinal systems," says Rachel Roper, a virologist at East Carolina University.

  • SARS-CoV-2 targets the ACE2 receptor on host cells to infect them. That receptor is expressed in many of the body’s tissues, and some studies find particles of the virus in heart, kidney and gut cells, suggesting it can get to other organs and possibly damage them directly.
  • Or it could be that the virus is impairing the body’s innate immune responses, affecting pathways that regulate key processes in the body, or causing inflammation — any of which may allow the virus to reach into unexpected organ systems.

There is the person it infects, with their genetics, behaviors and environment. A host of pre-existing conditions — for example, previous lung and heart disease — increases the risk of serious COVID-19 complications.

And there is the society that person lives in. Geographic and racial disparities in this pandemic suggest other factors, like the distribution of health services, may need to be considered, says C. Brandon Ogbunu, an assistant professor at Yale University who studies disease evolution and ecology.

  • "Even more so than other outbreaks, the variation from person to person, the multisystem nature, the way it hits demographics different, the way the disease manifests differently in national contexts — it defies a simple medical or biomedical narrative," he says.
  • COVID-19 may be more akin to noninfectious diseases — like diabetes and schizophrenia — that have complex interactions with sociological, historical and behavioral factors," says Ogbunu.

The bottom line: "The story of understanding COVID-19 has been the story of understanding these diversities," says Ogbunu. "This is a test of our modern understanding of what a disease is."

Editor's note: This story has been updated to clarify that the roughly 1 in 5 hospitalization rate for people who test positive for the disease pertains to older people.

Go deeper

Nov 1, 2020 - Health

WH accuses Fauci of playing politics over bleak coronavirus assessment

President Trump and NIAID director Anthony Fauci during a coronavirus task force briefing at the White House in April. Photo: Drew Angerer/Getty Images

NIAID director Anthony Fauci praised the Biden campaign's coronavirus stance, criticized White House adviser Scott Atlas and offered a bleak assessment of the U.S. pandemic response in an interview with the Washington Post, published Saturday.

Why it matters: Fauci's comments are perhaps his most frank yet and come as COVID-19 cases surge across the U.S. The White House called Fauci's remarks three days out from the election "unacceptable." Atlas publicly responded to his fellow coronavirus task force member in a tweet late Saturday.

Oct 31, 2020 - Health

New York rolls out new testing requirements for visitors

Gov. Andrew Cuomo. Photo: Spencer Platt/Getty Images

Gov. Andrew Cuomo (D) said Saturday he was replacing New York's weekly quarantine list with testing rules for out-of-state visitors, requiring travelers to test negative for COVID-19 before and after arrival, per WABC-TV.

Driving the news: The number of recorded coronavirus cases surpassed 9 million in the U.S. Friday, according to JHU, with the virus gaining strength in 41 states, including nearly every important battleground state.